Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

4,634 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A case of breast cholesterol granuloma accompanied by cancer.
Furuhira C, Ohshima A, Shimada K, Kuroki S, Nakano K, Ishikawa M, Yamamoto H, Tanaka M. Furuhira C, et al. Among authors: shimada k. Breast Cancer. 2004;11(2):210-3. doi: 10.1007/BF02968304. Breast Cancer. 2004. PMID: 15550870
Inhibition of the proliferation of acquired aromatase inhibitor-resistant breast cancer cells by histone deacetylase inhibitor LBH589 (panobinostat).
Kubo M, Kanaya N, Petrossian K, Ye J, Warden C, Liu Z, Nishimura R, Osako T, Okido M, Shimada K, Takahashi M, Chu P, Yuan YC, Chen S. Kubo M, et al. Among authors: shimada k. Breast Cancer Res Treat. 2013 Jan;137(1):93-107. doi: 10.1007/s10549-012-2332-x. Epub 2012 Nov 18. Breast Cancer Res Treat. 2013. PMID: 23160924 Free PMC article.
Role of HER2-Related Biomarkers (HER2, p95HER2, HER3, PTEN, and PIK3CA) in the Efficacy of Lapatinib plus Capecitabine in HER2-Positive Advanced Breast Cancer Refractory to Trastuzumab.
Nishimura R, Toh U, Tanaka M, Saimura M, Okumura Y, Saito T, Tanaka T, Teraoka M, Shimada K, Katayama K, Koga T, Kurashita K, Hasegawa S, Todoroki H, Kai Y, Ohi Y, Toyoshima S, Arima N, Mitsuyama S, Tamura K. Nishimura R, et al. Among authors: shimada k. Oncology. 2017;93(1):51-61. doi: 10.1159/000468521. Epub 2017 May 6. Oncology. 2017. PMID: 28478451
[Docetaxel in combination with epirubicin as the first-line chemotherapy for advanced and recurrent breast cancer: a multicenter phase II study].
Anan K, Tanaka M, Mitsuyama S, Imamura S, Ohno S, Hara S, Oikawa T, Fujii T, Nishimura R, Ishikawa E, Yano H, Taniguchi H, Ohkido M, Ohchi T, Chijiiwa K, Arime I, Shimada K, Inoue H, Tamura K; Kyushu Breast Cancer Study Group (KBC-SG). Anan K, et al. Among authors: shimada k. Gan To Kagaku Ryoho. 2012 May;39(5):747-52. Gan To Kagaku Ryoho. 2012. PMID: 22584325 Clinical Trial. Japanese.
4,634 results